Immune-related encephalitis after immune checkpoint inhibitor therapy.
Saved in:
| Title: | Immune-related encephalitis after immune checkpoint inhibitor therapy. |
|---|---|
| Authors: | Buckley MW; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Department of Neurology, University of Virginia School of Medicine, Charlottesville, VA 22903, United States., Balaji Warner A; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States., Brahmer J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States., Cappelli LC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Sharfman WH; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States., Fuchs E; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Kang H; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, United States., Forde PM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States., Gladstone DE; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; R.J. Zuckerberg Cancer Center at Hofstra/Northwell Health, Lake Success, NY 11042, United States., Ambinder R; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Kelly RJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX 75246, United States., Lipson EJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States., Gojo I; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Lee EJ; Maryland Oncology Hematology, Columbia, MD 21044, United States., Johnson TP; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Saidha S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Llinas R; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Ostrow LW; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Department of Neurology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, United States., Naidoo J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, United States.; Department of Oncology, Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, United States.; Department of Medicine, Beaumont Hospital Dublin and RCSI University of Health Sciences, Dublin, 9, Ireland., Probasco JC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States. |
| Source: | The oncologist [Oncologist] 2025 Jan 17; Vol. 30 (1). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyae186 |
